| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/03/2008 | WO2008000967A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same |
| 01/03/2008 | WO2008000881A1 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 01/03/2008 | WO2008000870A1 Organic compounds that inhibit the catalytic activity of the cyclin-dependent cyclin a/kinase 2 complex by means of bonding thereof to a new pharmacophoric site in the cyclin molecule |
| 01/03/2008 | WO2008000749A1 Detection of esr1 amplification in breast cancer |
| 01/03/2008 | WO2008000697A1 Novel 4-amino-3-(-azolyl-phenoxymethyl)-thieno[3,2]pyridine-7-carboxylic acid derivatives |
| 01/03/2008 | WO2008000643A1 Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same |
| 01/03/2008 | WO2008000517A2 Conjugates for innate immunotherapy of cancer |
| 01/03/2008 | WO2008000131A1 α-AMINO-N-SUBSTITUTED AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF |
| 01/03/2008 | WO2008000079A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/03/2008 | WO2008000070A1 Glycyrrhetinic acid derivatives |
| 01/03/2008 | WO2007128829A3 18,21-didesoxymacbecin derivatives for the treatment of cancer |
| 01/03/2008 | WO2007126455A3 Method for using boc/cdo to modulate hedgehog signaling |
| 01/03/2008 | WO2007118198A3 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
| 01/03/2008 | WO2007113005A3 2-substituted 3-aminosulfonyl-thiophene derivatives as aurora kinase inhibitors |
| 01/03/2008 | WO2007112121A3 Tetracycline compounds and methods of treatment |
| 01/03/2008 | WO2007006581A3 Targeting lsd1 for use in identifying and/or scoring prostate cancer and for controlling anrogen receptor-dependent gene expression |
| 01/03/2008 | WO2006113942A3 Method of inhibiting cathepsin activity |
| 01/03/2008 | WO2005047505A3 Methods and products for expression of micro rnas |
| 01/03/2008 | WO2005019200A3 Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof |
| 01/03/2008 | US20080004355 Method for Inhibiting Telomerase Activity and an Agent for Inhibiting the Same |
| 01/03/2008 | US20080004347 serotonin (5-HT2C) receptor antagonist; antidepressant, anxiolytic agent; seasonal affective disorders, sleep disorders, cardiovascular pathologies, pathologies of the digestive system, insomnia and fatigue resulting from jetlag, appetite disorders and obesity |
| 01/03/2008 | US20080004345 Novel Water-Soluble Fullerene, Process for Producing the Same and Active Oxygen Generator Containing the Fullerene |
| 01/03/2008 | US20080004342 Fatty acid phenolic conjugates |
| 01/03/2008 | US20080004326 Method of Obtaining Idolocarbazoles Using Biosynthetic Rebeccamycin Genes |
| 01/03/2008 | US20080004318 Substituted Bicyclic and Tricyclic Thrombin Receptor Antagonists |
| 01/03/2008 | US20080004308 Azaindole inhibitors of aurora kinases |
| 01/03/2008 | US20080004297 Compounds and therapeutical use thereof |
| 01/03/2008 | US20080004294 Heterocyclic compounds |
| 01/03/2008 | US20080004280 Heterocyclic topoisomerase poisons |
| 01/03/2008 | US20080004277 Triazole compounds that modulate HSP90 activity |
| 01/03/2008 | US20080004276 Method for treating non-hodgkin's lymphoma |
| 01/03/2008 | US20080004271 Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith |
| 01/03/2008 | US20080004270 3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors |
| 01/03/2008 | US20080004267 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | US20080004266 Method for treating proliferative disorders associated with protooncogene products |
| 01/03/2008 | US20080004259 Anticancer agents; initiating mitosis which causes tumor cell death |
| 01/03/2008 | US20080004257 Kinase inhibitors |
| 01/03/2008 | US20080004251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor |
| 01/03/2008 | US20080004248 prostate cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, androgenic alopecia, precocious puberty, adrenal hyperlasia and polycystic ovarian syndrome, breast cancer, endometriosis, leiomyoma and precocious puberty, estrogen dependent diseases |
| 01/03/2008 | US20080004239 Boronated Metal-Phthalocyanines, Process For Their Preparation, Pharmaceutical Compositions Comprising Them And Use Thereof |
| 01/03/2008 | US20080004233 Delta-Tocotrienol Treatment and Prevention of Pancreatic Cancer |
| 01/03/2008 | US20080004229 Methods and Compositions Related to Skcg-1, a Tumor Suppressor |
| 01/03/2008 | US20080003304 Combination chemotherapy |
| 01/03/2008 | US20080003294 Methods for pulmonary delivery of interleukin-2 |
| 01/03/2008 | US20080003293 Use of Buckysome or Carbon Nanotube for Drug Delivery |
| 01/03/2008 | US20080003283 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 01/03/2008 | US20080003271 Moisturizing, cosmetic, or anti-wrinkle composition comprising at least two hyaluronic acid fractions or salts thereof, wherein first fraction has molecular weight of 8,000-100,000 Da, and second fraction has molecular weight of 500,000-1,100,000 Da; may also have use in treating osteoarthritis, cancer |
| 01/03/2008 | US20080003235 Vaccine Composition Comprising a Class II Cmh Lignd Coupled With an Antigen, Method for the Preparation and the Use Thereof |
| 01/03/2008 | US20080003229 the polypeptide induces an immune response directed both against the immunodominant region and against the protein of the host; vaccine |
| 01/03/2008 | US20080003224 Compositions and methods for treating haematological proliferative disorders |
| 01/03/2008 | US20080003222 Inhibitors for L1 and Adam10 for the Treatment of Carcinomas |
| 01/03/2008 | US20080003216 Administering an interleukin-18 binding protein (IL-18BP) for inhibiting melanoma cell liver and lung tissue metastasis; IL-18 (IFN gamma-inducing factor) |
| 01/03/2008 | US20080003200 Tissue selective binding for prostate and/or bone cancer, or adipose tissue; apoptosis induction; diagnosis, prognosis; staging metastatic cancer |
| 01/03/2008 | US20080003183 Nanoparticle radiosensitizers |
| 01/03/2008 | US20080003177 Radioactive arsenic-containing compounds and their uses in the treatment of tumors |
| 01/03/2008 | DE102006030164A1 Inhalative Pulver Inhalation powder |
| 01/03/2008 | DE102006029795A1 Neue Harnstoff-Derivate und deren Verwendungen New urea derivatives and their uses |
| 01/03/2008 | DE102006020444A1 Transgenic mesenchymal stem cells stably expressing tumor necrosis factor-related apoptosis-inducing ligand, e.g. useful for treating tumors |
| 01/03/2008 | CA2660782A1 Organic compounds |
| 01/03/2008 | CA2657107A1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | CA2657096A1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | CA2656564A1 Biaryl compositions and methods for modulating a kinase cascade |
| 01/03/2008 | CA2656159A1 Pyridylisoxazole derivatives |
| 01/03/2008 | CA2656107A1 Cancer therapy using bcl-xl-specific sina |
| 01/03/2008 | CA2655913A1 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
| 01/03/2008 | CA2655546A1 Detection of esr1 amplification in breast cancer |
| 01/03/2008 | CA2655398A1 4-amino-3-(3-azolyl-phenoxymethyl)-thieno[3,2-c]pyridine-7-carboxylic acid derivatives and uses thereof for treating cancer, atherosclerosis and restenosis |
| 01/03/2008 | CA2654936A1 Use of hdac inhibitors for the treatment of lymphomas |
| 01/03/2008 | CA2654852A1 Pyrimidine derivatives useful in the treatment of cancer |
| 01/03/2008 | CA2653756A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/03/2008 | CA2653726A1 Glycyrrhetinic acid derivatives |
| 01/03/2008 | CA2652811A1 Potentiator of radiation therapy |
| 01/02/2008 | EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs |
| 01/02/2008 | EP1873258A1 Detection of ESR1 amplification in breast cancer |
| 01/02/2008 | EP1873240A1 hTERT GENE EXPRESSION REGULATORY GENE |
| 01/02/2008 | EP1873204A1 Polymeric pharmaceutical agent for treatment of cancer and process for production of the same |
| 01/02/2008 | EP1873157A1 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 01/02/2008 | EP1873154A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF |
| 01/02/2008 | EP1873140A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/02/2008 | EP1873139A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/02/2008 | EP1872800A2 Radiolabeled peptide compositions for site-specific targeting |
| 01/02/2008 | EP1872798A1 Intestinal absorptive anti-tumor agent |
| 01/02/2008 | EP1872793A1 Polyamino acid for use as adjuvant |
| 01/02/2008 | EP1872782A1 Drug for treating or diagnosing vascular lesion in the skin or the subcutaneous soft tissue caused by light irradiation |
| 01/02/2008 | EP1871882A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
| 01/02/2008 | EP1871776A2 Fused thieno[2,3-b]pyridine and thiazolo[5,4-b]pyridine compounds for inhibiting ksp kinesin activity |
| 01/02/2008 | EP1871773A1 N-[3-(1-amino-5,6,7,8-tetrahydro-2,4,4b-triazafluoren-9-yl)-phenyl]benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 01/02/2008 | EP1871771A1 4-(pyrid-2-yl) amino substituted pyrimidine as protein kinase inhibitors |
| 01/02/2008 | EP1871765A2 3-(indazol-5-yl)-(1,2,4)triazine derivatives and related compounds as protein kinase inhibitors for the treatment of cancer |
| 01/02/2008 | EP1871484A2 Sema4d in cancer diagnosis, detection and treatment |
| 01/02/2008 | EP1871424A2 Immunoliposome composition for targeting to a her2 cell receptor |
| 01/02/2008 | EP1871422A2 Uses of rhcc peptide in drug delivery, renal filtering, chemical catalysis and production of nanoparticles |
| 01/02/2008 | EP1871418A2 Humanized anti-cd70 binding agents and uses thereof |
| 01/02/2008 | EP1871417A2 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 01/02/2008 | EP1871415A2 Composition for treating cancer adapted for intra-tumoral asministration and uses thereof |
| 01/02/2008 | EP1871406A1 Treatment of egfr dependent tumors by abin (a20-binding inhibitor of nf kappab) |
| 01/02/2008 | EP1871392A1 Modulating angiogenesis with nod factors such as glucosamine oligosaccharides |
| 01/02/2008 | EP1871376A2 Inhibitors of akt activity |
| 01/02/2008 | EP1871375A2 Carboline derivatives useful in the treatment of cancer |
| 01/02/2008 | EP1871371A2 Use of an epidermal growth factor receptor kinase inhibitor (egfr) in gefitinib resistant patients |